Hostname: page-component-848d4c4894-75dct Total loading time: 0 Render date: 2024-06-12T09:47:43.693Z Has data issue: false hasContentIssue false
  • English
  • Français

The behavioural actions of the hypothalamic peptides: a review

Published online by Cambridge University Press:  09 July 2009

B. T. Donovan
B. T. Donovan*
Affiliation:
Department of Physiology, Institute of Psychiatry, London
*
1Address for correspondence: Professor B.T. Donovan, Department of Physiology, Institute of Psychiatry, De Crespigny Park, Denmark Hill, London SE5 8AF.
Get access Rights & Permissions [Opens in a new window]

Synopsis

Recent work has shown that the hypothalamic peptides commonly associated with the control of pituitary function have important behavioural actions of possible psychiatric significance. Thus, vasopressin, ACTH and like peptides may influence memory processes, and ACTH and MSH given intracranially induce a peculiar stretching and yawning syndrome accompanied by penile erection and ejaculation. Thyrotrophic hormone-releasing factor potentiates behavioural excitation, somatostatin is depressive, while luteinizing hormone-releasing hormone facilitates sexual behaviour and the newly identified endorphins are markedly opioid in character. These and other activities of the hypothalamic peptides are reviewed and assessed alongside the clinical information available.

Type
Research Article
Information
Psychological Medicine , Volume 8 , Issue 2 , May 1978 , pp. 305 - 316
Copyright
Copyright © Cambridge University Press 1978

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Amoss, M., Burgus, R., Blackwell, R., Vale, W., Fellows, R. & Guillemin, R. (1971). Purification, amino acid composition and N-terminus of the hypothalamic luteinizing hormone releasing factor (LRF) of ovine origin. Biochemical and Biophysical Research Communications 44, 205–210.CrossRefGoogle ScholarPubMed
Baldwin, D. M., Haun, C. K. & Sawyer, C. H. (1974). Effects of intraventricular infusions of ACTH 1–24 and ACTH 4–10 on LH release, ovulation and behavior in the rabbit. Brain Research 80, 291–301.CrossRefGoogle Scholar
Bertolini, A., Gessa, G. L. & Ferrari, W. (1975). Penile erection and ejaculation: a central effect of ACTH-like peptides in mammals. In: Sexual Behavior: Pharmacology and Biochemistry (ed. Sandler, M. and Gessa, G. L.), pp. 247–257. Raven Press: New York.Google Scholar
Bloom, F., Segal, D., Ling, N. & Guillemin, R. (1976). Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness. Science 194, 630–632.CrossRefGoogle ScholarPubMed
Breese, G. R., Cott, J. M., Cooper, B. R., Prange, A. J. Jr, Lipton, M. A. & Plotnikoff, N. P. (1975). Effects of thyrotropin-releasing hormone (TRH) on the actions of pentobarbital and other centrally acting drugs. Journal of Pharmacology and Experimental Therapeutics 193, 11–22.Google ScholarPubMed
Cohn, M. L., Cohn, M., Krzysik, B. A. & Taylor, F. H. (1976). Regulation of behavioral events by thyrotropin releasing factor and cyclic AMP. Pharmacology, Biochemistry and Behavior 5 (Suppl. 1), 129–133.CrossRefGoogle ScholarPubMed
Crowley, W. R., Rodriguez-Sierra, J. F. & Komisaruk, B. R. (1976). Hypophysectomy facilitates sexual behavior in female rats. Neuroendocrinology 20, 328–338.CrossRefGoogle ScholarPubMed
Davies, T. F., Mountjoy, C. Q., Gomez-Pan, A., Watson, M. J., Hanker, J. P., Besser, G. M. & Hall, R. (1976). A double blind cross over trial of gonadotrophin releasing hormone (LHRH) in sexually impotent men. Clinical Endocrinology 5, 601–607.CrossRefGoogle ScholarPubMed
Davis, G. C., Bunney, W. E., Defraites, E. G., Kleinman, J. E., van Kammen, D. P., Post, R. M. & Wyatt, R. J. (1977). Intravenous naloxone administration in schizophrenia and affective illness. Science 197, 74–77.CrossRefGoogle ScholarPubMed
Davis, K. L., Hollister, L. E. & Berger, P. A. (1975). Thyrotropin-releasing hormone in schizophrenia. American Journal of Psychiatry 132, 951–953.Google ScholarPubMed
Dornbush, R. L. & Nikolovski, O. (1976). ACTH 4–10 and short-term memory. Pharmacology, Biochemistry and Behavior 5 (Suppl. 1), 69–72.CrossRefGoogle ScholarPubMed
Dupont, A., Cusan, L., Garon, M., Labrie, F. & Li, C. H. (1977 a). Beta-endorphin: stimulation of growth hormone release in vivo. Proceedings of the National Academy of Sciences 74, 358–359.CrossRefGoogle Scholar
Dupont, A., Cusan, L., Labrie, F., Coy, D. H. & Li, C. H. (1977b). Stimulation of prolactin release in the rat by intraventricular injection of β-endorphin and methionineenkephalin. Biochemical and Biophysical Research Communications 75, 76–82.CrossRefGoogle ScholarPubMed
Ehrensing, R. H. & Kastin, A. J. (1974). Melanocyte-stimu-lating hormone-release inhibiting hormone as an antidepressant. A pilot study. Archives of General Psychiatry 30, 63–65.CrossRefGoogle ScholarPubMed
Ehrensing, R. H., Kastin, A. J., Schalch, D. S., Friesen, H., Vargas, J. R. & Schally, A. V. (1974). Affective state and thyrotropin and prolactin responses after repeated injections of thyrotropin-releasing hormone in depressed patients. American Journal of Psychiatry 131, 714–718.CrossRefGoogle ScholarPubMed
Ferris, S. H., Sathananthan, G., Gershon, S., Clark, C. & Moshinsky, J. (1976). Cognitive effects of ACTH 4–10 in the elderly. Pharmacology, Biochemistry and Behavior 5 (Suppl. 1), 73–78.CrossRefGoogle ScholarPubMed
Frederickson, R. C. A. (1977). Enkephalin pentapeptides – a review of current evidence for a physiological role in vertebrate neurotransmission. Life Sciences 21, 23–41.CrossRefGoogle ScholarPubMed
Furlong, F. W., Brown, G. M. & Beeching, M. F. (1976). Thyrotropin-releasing hormone: differential antidepressant and endocrinological effects. American Journal of Psychiatry 133, 1187–1190.Google ScholarPubMed
Gaillard, A. W. K. & Sanders, A. F. (1975). Some effects of ACTH 4–10 on performance during a serial reaction task. Psychopharmacologia 42, 201–208.CrossRefGoogle ScholarPubMed
Goldstein, A. (1976). Opioid peptides (endorphins) in pituitary and brain. Science 193, 1081–1086.CrossRefGoogle ScholarPubMed
Guansing, A. R. & Murk, L. M. (1976). Distribution of thyrotropin-releasing hormone in human brain. Hormone and Metabolic Research 8, 493–494.CrossRefGoogle ScholarPubMed
Guillemin, R. (1977). Biochemical and physiological correlates of hypothalamic peptides. The new endocrinology of the neuron. Proceedings of the Association for Research in Nervous and Mental Diseases (in the press).Google Scholar
Guillemin, R. & Gerich, J. E. (1976). Somatostatin: physiological and clinical significance. Annual Review of Medicine 27, 379–388.CrossRefGoogle ScholarPubMed
Guillemin, R., Vargo, T., Rossier, J., Minick, S., Ling, N., Rivier, C., Vale, W. & Bloom, F. (1977). β-endorphin and adrenocorticotropin are secreted concomitantly by the pituitary gland. Science 197, 1367–1369.CrossRefGoogle ScholarPubMed
Gunne, L.-M., Lindström, L. & Terenius, L. (1977). Nal-oxone-induced reversal of schizophrenic hallucinations. Journal of Neural Transmission 40, 13–19.CrossRefGoogle ScholarPubMed
Horrobin, D. F., Mtabaji, J. P., Karmali, R. A., Manku, M. S. & Nassar, B. A. (1976). Prolactin and mental illness. Postgraduate Medical Journal 52 (Suppl. 3), 79–85.Google ScholarPubMed
Hughes, J., Smith, T. W., Kosterlitz, H. W., Fothergill, L. A., Morgan, B. A. & Morris, H. R. (1975). Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258, 577–579.CrossRefGoogle ScholarPubMed
Jacquet, Y. F. & Marks, N. (1976). The C-fragment of β-lipotropin: an endogenous neuroleptic or antipsychotogen. Science 194, 632–635.CrossRefGoogle ScholarPubMed
Kastin, A. J. & Barbeau, A. (1972). Preliminary clinical studies with l-prolyl-l-leucyl-glycine amide in Parkinson's disease. Canadian Medical Association Journal 107, 1079–1081.Google ScholarPubMed
Kastin, A. J., Ehrensing, R. H., Schalch, D. S. & Anderson, M. S. (1972). Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin-releasing hormone. Lancet ii, 740–742.CrossRefGoogle Scholar
Kastin, A. J., Plotnikoff, N. P., Sandman, C. A., Spirtes, M. A., Kostrzewa, R. M., Paul, S. M., Stratton, L. O., Miller, L. H., Labrie, F., Schally, A. V. & Goldman, H. (1975a). The effects of MSH and MIF on the brain. In Anatomical Neuroendocrinology (ed. Stumpf, W. E. and Grant, L. D.), pp. 290–297. Karger: Basel.Google Scholar
Kastin, A. J., Sandman, C. A., Stratton, L. O., Schally, A. V. & Miller, L. H. (1975b). Behavioral and electrographic changes in rat and man after MSH. Progress in Brain Research 42, 143–150.CrossRefGoogle ScholarPubMed
Keller, H. H., Bartholini, G. & Pletscher, A. (1974). Enhancement of cerebral noradrenaline turnover by thyrotropin-releasing hormone. Nature 248, 528–529.CrossRefGoogle ScholarPubMed
Keye, W. R., Young, J. R. & Jaffe, R. B. (1976). Hypothalamic gonadotropin releasing hormone: physiologic and chemical considerations. Obstetrical and Gynecological Survey 31, 635–654.CrossRefGoogle Scholar
Kiely, W. F., Adrian, A. D., Lee, J. H. & Nicoloff, J. T. (1976). Therapeutic failure of oral thyrotropin-releasing hormone in depression. Psychosomatic Medicine 38, 233–241.CrossRefGoogle ScholarPubMed
Krieger, D. T., Liotta, A. & Brownstein, M. J. (1977). Presence of corticotropin in brain of normal and hypophysectomized rats. Proceedings of the National Academy of Sciences 74, 648–652.CrossRefGoogle ScholarPubMed
Lien, E. L., Fenichel, R. L., Garsky, V., Sarankatis, D. & Grant, N. H. (1976). Enkephalin-stimulated prolactin release. Life Sciences 19, 837–840.CrossRefGoogle ScholarPubMed
Lindström, L. H., Gunne, L.-M., Öst, L.-G. & Persson, E. (1977). Thyrotropin-releasing hormone (TRH) in chronic schizophrenia: a controlled study. Acta Psychiatrica Scandinavica 55, 74–80.CrossRefGoogle ScholarPubMed
Mayer, D. J., Price, D. D. & Rafii, A. (1977). Antagonism of acupuncture analgesia in man by the narcotic antagonist naloxone. Brain Research 121, 368–372.CrossRefGoogle Scholar
Meglio, M., Hosobuchi, Y., Loh, H. H., Adams, J. E. & Li, C. H. (1977). β-endorphin: behavioral and analgesic activity in cats. Proceedings of the National Academy of Sciences 74, 774–776.CrossRefGoogle ScholarPubMed
Miller, L. H., Harris, L. C., van Riezen, H. & Kastin, A. J. (1976). Neuroheptapeptide influence on attention and memory in man. Pharmacology, Biochemistry and Behavior 5 (Suppl. 1), 17–21.CrossRefGoogle ScholarPubMed
Mortimer, C. H., McNeilly, A. S., Fisher, R. A., Murray, M. A. F. & Besser, G. M. (1974). Gonadotrophin-releasing hormone therapy in hypogonadal males with hypothalamic or pituitary dysfunction. British Medical Journal iv, 617–621.CrossRefGoogle Scholar
Moss, R. L. & McCann, S. M. (1973). Induction of mating behavior in rats by luteinizing hormone-releasing factor. Science 181, 177–179.CrossRefGoogle ScholarPubMed
Moss, R. L. & McCann, S. M. (1975). Action of luteinizing hormone-releasing factor (LRF) in the initiation of lordosis behavior in the estrone-primed ovariectomized female rat. Neuroendocrinology 17, 309–318.CrossRefGoogle ScholarPubMed
Mountjoy, C. Q. (1976). The possible role of thyroid and thyrotrophic hormones in depressive illness. Postgraduate Medical Journal 52 (Suppl. 3), 103–107.Google ScholarPubMed
Ormston, B. J., Garry, R., Cryer, R. J., Besser, G. M. & Hall, R. (1971). Thyrotrophin-releasing hormone as a thyroid-function test. Lancet ii, 10–14.CrossRefGoogle Scholar
Pfaff, D. W. (1973). Luteinizing hormone-releasing factor potentiates lordosis behavior in hypophysectomized ovariectomized female rats. Science 182, 1148–1149.CrossRefGoogle ScholarPubMed
Panksepp, J., Reilly, P., Bishop, P., Meeker, R. B., Vilberg, T. R. & Kastin, A. J. (1976). Effects of α-MSH on motivation, vigilance and brain respiration. Pharmacology, Biochemistry and Behavior 5 (Suppl. 1), 59–64.CrossRefGoogle Scholar
Pomerantz, B., Cheng, R. & Law, P. (1977). Acupuncture reduces electrophysiological and behavioral responses to noxious stimuli: pituitary is implicated. Experimental Neurology 54, 172–178.CrossRefGoogle Scholar
Prange, A. J., Wilson, I. C., Lara, P. P., Alltop, L. B. & Breese, G. R. (1972). Effects of thyrotropin-releasing hormone in depression. Lancet ii, 999–1002.CrossRefGoogle Scholar
Prange, A. J. Jr, Breese, G. R., Wilson, I. C. & Lipton, M. A. (1975a). Brain-behavioral effects of hypothalamic releasing hormones. A generic hypothesis. In Anatomical Neuroendocrinology (ed. Stumpf, W. E. and Grant, L. D.), pp. 357–366. Karger: Basel.Google Scholar
Prange, A. J., Wilson, I. C., Breese, G. R. & Lipton, M. A. (1975 b). Behavioral effects of hypothalamic releasing hormones in animals and men. Progress in Brain Research 42, 1–9.CrossRefGoogle Scholar
Reichlin, S., Saperstein, R., Jackson, I. M. D., Boyd, A. E. & Patel, Y. (1976). Hypothalamic hormones. Annual Review of Physiology 38, 389–424.CrossRefGoogle ScholarPubMed
Reith, M. E. A., Schotman, P., Gispen, W. H. & de Wied, D. (1977). Pituitary peptides as modulators of neural functioning. Trends in Biochemical Sciences 2, 56–58.CrossRefGoogle Scholar
Rezek, M., Havlicek, V., Hughes, K. R. & Friesen, H. (1976). Central site of action of somatostatin (SR1F): role of hippocampus. Neuropharmacology 15, 499–504.CrossRefGoogle Scholar
Rezek, M., Havlicek, V., Hughes, K. R. & Friesen, H. (1977). Behavioural and motor excitation and inhibition induced by the administration of small and large doses of somatostatin into the amygdala. Neuropharmacology 16, 157–162.CrossRefGoogle ScholarPubMed
Rivier, C., Vale, W., Ling, N., Brown, M. & Guillemin, R. (1977). Stimulation in vivo of the secretion of prolactin and growth hormone by β-endorphin. Endocrinology 100, 238–241.CrossRefGoogle ScholarPubMed
Sandman, C. A., George, J., Walker, B. B., Nolan, J. D. & Kastin, A.J. (1976). Neuropeptide MSH/ACTH 4–10 enhances attention in the mentally retarded. Pharmacology, Biochemistry and Behavior 5 (Suppl. 1), 23–28.CrossRefGoogle ScholarPubMed
Schally, A. V., Arimura, A., Baba, Y., Nair, R. M. G., Matsuo, H., Redding, T. W., Debeljuk, L. & White, W. F. (1971). Isolation and properties of the FSH and LH-releasing hormone. Biochemical and Biophysical Research Communications 43, 393–399.CrossRefGoogle ScholarPubMed
Schmidt, J. (1977). Treatment of endogenous depressions with thyrotropin-releasing hormone (TRH) under oral administration. Acta Psychiatrica Scandinavica 55, 142–146.CrossRefGoogle ScholarPubMed
Siler, T. M., Vandenberg, G. & Yen, S. S. C. (1973). Inhibition of growth hormone release in humans by somatostatin. Journal of Clinical Endocrinology 37, 632–634.CrossRefGoogle ScholarPubMed
Snyder, S. H. (1977). Opiate receptors in the brain. New England Journal of Medicine 296, 266–271.CrossRefGoogle ScholarPubMed
Snyder, S. H. & Simantov, R. (1977). The opiate receptor and opioid peptides. Journal of Neurochemistry 28, 13–20.CrossRefGoogle Scholar
Vale, W., Rivier, C. & Brown, M. (1977). Regulatory peptides of the hypothalamus. Annual Review of Physiology 39, 473–527.CrossRefGoogle ScholarPubMed
de Wied, D. (1969). Effects of peptide hormones on behavior. In Frontiers in Neuroendocrinology, 1969 (ed. Ganong, W. F. and Martini, L.), pp. 97–140. Oxford University Press: New York.Google Scholar
de Wied, D. (1977). Peptides and behavior. Life Sciences 20, 195–204.CrossRefGoogle ScholarPubMed
de Wied, D., Witter, A. & Greven, H. M. (1975). Behaviourally active ACTH analogues. Biochemical Pharmacology 24, 1463–1468.CrossRefGoogle ScholarPubMed
Wilber, J. F., Montoya, E., Plotnikoff, N. P., White, W. F., Gendrich, R., Renaud, L. & Martin, J. B. (1976). Gonadotropin-releasing hormone and thyrotropin-releasing hor mone: distribution and effects in the central nervous system. Recent Progress in Hormone Research 32, 117–153.Google Scholar
Wilson, I. C., Lara, P. P. & Prange, A. J. Jr (1973). Thyrotropin-releasing hormone in schizophrenia. Lancet ii, 43–44.CrossRefGoogle Scholar
van Wimersma Greidanus, Tj. B., Bohus, B. & de Wied, D. (1975a). The role of vasopressin in memory processes. Progress in Brain Research 42, 135–141.CrossRefGoogle ScholarPubMed
van Wimersma Greidanus, Tj. B., Bohus, B. & de Wied, D. (1975 b). CNS sites of action of ACTH, MSH and vasopressin in relation to avoidance behavior. In Anatomical Neuroendocrinology (ed. Stumpf, W. E. and Grant, L. D.), pp. 284–289. Karger: Basel.Google Scholar